Brand Name(s):Striant SR
Indication:Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been diagnosed by an endocrinologist and confirmed by clinical features and biochemical tests
Rationale:
Considered:Apr-11
Review Date:Apr-21
Comments:
Initiation must only be made by an endocrinologist on diagnosis of male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
Drug must be initiated and titrated to stable dosage by endocrinologist before GPs take over prescribing responsibility. Once medical condition and drug dosage is stable, there is no specific requirement for ongoing monitoring to be completed by GPs
All ongoing monitoring, including Testosterone levels, Prostate exam, FBC, Lipid profile and LFT’s will be completed by endocrinology at intervals defined by the consultant.
Any dosage adjustments required will be completed by the endocrinologist and a letter will be sent to the GP informing them of this change
Dosages will be prescribed in accordance with the Summary of Product Characteristics
Doncaster & Bassetlaw Area Prescribing Committee
DBHFT Endocrinology
November 2010